Moreover, overexpression of BDNF and TrkB has been demonstrated to act as a predictor of a poor clinical outcome and a worse survival when patients are suffering from human bladder cancer, neuroblastoma and breast carcinoma [20–22]. The gene discussed is BDNF; the disease is breast carcinoma.